ACHC

ACHC

USD

Acadia Healthcare Company Inc. Common Stock

$22.150-0.030 (-0.135%)

Real-time Price

Healthcare
Medical Care Facilities
United States

Price Chart

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$22.180

High

$22.540

Low

$21.710

Volume

0.01M

Company Fundamentals

Market Cap

2.0B

Industry

Medical Care Facilities

Country

United States

Trading Stats

Avg Volume

2.25M

Exchange

NMS

Currency

USD

52-Week Range

Low $20.36Current $22.150High $82.41

AI Analysis Report

Last updated: Apr 28, 2025
AI-GeneratedData Source: Yahoo Finance, Bloomberg, SEC

ACHC: Acadia Healthcare Company Inc. Common Stock - Analyzing Recent Moves & What Might Come Next

Stock Symbol: ACHC Generate Date: 2025-04-28 17:22:58

Alright, let's break down what's been going on with Acadia Healthcare (ACHC) and what the data we have might suggest. Think of this as looking at the puzzle pieces to see the potential picture.

What's Been Happening? (News & Price Check)

First off, the news front has been a bit of a mixed bag lately, at least regarding analyst opinions. Back in late March, Mizuho kept a "Neutral" rating on the stock but actually lowered their price target from $48 down to $37. That's not exactly a ringing endorsement, especially the lower target part. Fast forward to early April, and Guggenheim steps in with a "Buy" rating, setting their price target at $36. So, you've got one firm saying "Neutral" with a $37 target and another saying "Buy" with a $36 target. Both targets are well above where the stock is trading now, but the ratings themselves offer different takes. The overall vibe from these two pieces is cautiously optimistic from the analyst perspective, but the lowered target from Mizuho adds a note of caution.

Now, let's look at the stock price itself over the last three months or so. The chart tells a pretty clear story of a significant drop. Back in late January, shares were trading up around the $44-$45 mark. Then came a sharp decline, particularly noticeable around late February, dropping into the low $30s. The slide didn't stop there; the price has continued to drift lower, hitting the low $20s recently. The current price is sitting right around $21.89. This is a dramatic fall from those earlier levels and puts the stock near its 52-week low of $20.36. So, while analysts have targets much higher, the actual price action has been strongly negative for quite some time.

Looking Ahead (Predictions & Analyst Views)

We've got some AI predictions for the very near term. The model suggests today's price change might be flat (0.00%), but it forecasts a small bounce over the next couple of days: a 2.00% increase tomorrow and another 3.15% the day after. This suggests the AI sees a potential short-term uptick from the current depressed levels.

Beyond the immediate AI prediction, the broader analyst picture (as summarized in the recommendation data) is quite interesting. It mentions a strong buy rating from 13 analysts with a much higher average price target of $46.38. This implies a potential upside of over 100% from the current price if those analysts are right over the longer term. The AI prediction model also shows high confidence and projects an upward trend with a potential target price of $1.02 (this specific number seems low compared to the percentage predictions and analyst targets, likely a different scale or short-term view, but the direction is upward).

Putting It All Together (Outlook & Ideas)

So, what does this mix of information tell us? The recent price trend for ACHC has been undeniably tough, showing a significant decline over the past few months, bringing it down near its yearly low. However, the analyst community, on average, seems to believe the stock is worth significantly more than its current trading price, with some initiating or maintaining positive ratings and high price targets. The AI model also points to a potential small bounce in the very near term from these low levels.

Given the sharp drop and the disconnect between the current price and analyst targets, alongside the AI predicting a short-term positive move, the situation might lean towards a potential opportunity for those comfortable with risk, if they believe the stock is undervalued at these levels and the analyst/AI outlook will eventually influence the price.

  • Potential Entry Consideration: If someone were considering getting in, the current price area, hovering just above the 52-week low and aligning with the AI's predicted starting point for a bounce, could be a point of interest. The recommendation data also highlighted entry points around $22.16 - $22.28, which is right where the stock is now. This area looks interesting because it's near a significant low point, potentially offering a better entry price if a turnaround were to occur.
  • Potential Exit/Stop-Loss Consideration: Managing risk is key. The recommendation data suggests a potential stop-loss level around $19.92. This is just below the 52-week low, acting as a point to potentially cut losses if the price continues to fall significantly. For taking profits, the recommendation data gives a very near-term target of $22.58, which aligns with the AI's predicted bounce range. Longer-term profit targets would be much higher, closer to the analyst averages, but those come with more uncertainty and a longer time horizon.

It's important to remember there are also fundamental concerns noted, like high debt and lower growth/ROE compared to some benchmarks, plus a technical MACD "death cross" signal which is typically seen as bearish. These factors could weigh on the stock.

A Bit About the Company

Just for context, Acadia Healthcare is in the Medical Care Facilities part of the Healthcare sector. They focus on providing behavioral healthcare services. So, news or trends related to mental health, addiction treatment, or healthcare policy could definitely impact their business and stock price. They have a good number of employees (over 19,000), indicating a substantial operation.

Important Note

This analysis is based only on the data provided and is intended for informational purposes. It's like getting one opinion; it's not financial advice. Stock markets are unpredictable, and prices can go down as well as up. Before making any investment decisions, you should always do your own thorough research, consider your own financial situation and risk tolerance, and ideally, consult with a qualified financial advisor.

Related News

Analyst Upgrades

Guggenheim Initiates Coverage On Acadia Healthcare Co with Buy Rating, Announces Price Target of $36

Guggenheim analyst Jason Cassorla initiates coverage on Acadia Healthcare Co with a Buy rating and announces Price Target of $36.

View more
Guggenheim Initiates Coverage On Acadia Healthcare Co with Buy Rating, Announces Price Target of $36
Analyst Upgrades

Mizuho Maintains Neutral on Acadia Healthcare Co, Lowers Price Target to $37

Mizuho analyst Ann Hynes maintains Acadia Healthcare Co with a Neutral and lowers the price target from $48 to $37.

View more
Mizuho Maintains Neutral on Acadia Healthcare Co, Lowers Price Target to $37

AI PredictionBeta

AI Recommendation

Bullish

Updated at: Apr 28, 2025, 01:34 AM

BearishNeutralBullish

65.3% Confidence

Risk & Trading

Risk Level3/5
Medium Risk
Suitable For
Value
Trading Guide

Entry Point

$22.16

Take Profit

$22.58

Stop Loss

$19.92

Key Factors

PDI 7.4 is above MDI 7.0 with ADX 15.9, suggesting bullish trend
Current Price is extremely close to support level ($22.12), suggesting strong buying opportunity
Trading volume is 6.8x average (26,775), indicating extremely strong buying pressure
MACD 0.0308 is below signal line 0.0342, indicating a bearish crossover

Stay Updated

Set price alerts, get AI analysis updates and real-time market news.